Next Generation DX Summit 2018

Suman Bose of Massachusetts Institute of Technology speaks to CHI on May 3, 2018. Dr. Bose will be speaking at the Single Cell Analysis and at the Microfluidics and Lab-on-a-Chip Devises for point of care testing tracks at the upcoming Next Generation Diagnostics Summit that is held from August 20th through the 24th in Washington, D.C.
 
Topics include motivation for single cells analysis, overcoming challenges and outlooks for the Summit.  For more information, please visit http://www.NextGenerationDX.com/Microfluidics/ and http://www.NextGenerationDX.com/Single-Cell-Analysis/

Next Generation DX Summit 2018 | Rapid Fire: Getting to Know Suman Bose

Paul Yager of University of Washington speaks to CHI on May 4, 2018. Dr. Paul Yager from the University of Washington. Dr. Yager will be speaking at the Enabling Point-of-Care Diagnostics and the Microfluidics and Lab-on-a-Chip Devices for point-of-care testing tracks at the upcoming Next Generation Diagnostic Summit that is held from August 20th to the 24th in Washington, DC.
 
Topics include his lab’s success in developing NAAT testing, obstacles to developing low cost diagnostics and advice for those looking to get into the field.  For more information, please visit http://www.NextGenerationDX.com/Point-of-Care-Diagnostics/ and http://www.NextGenerationDX.com/Microfluidics/

Next Generation DX Summit 2018 | Developing Low Cost Diagnostics for Infectious Disease

Daryl Pritchard of PMC speaks to CHI on May 4th, 2018. Darryl will be speaking at a shared session between the Coverage and Reimbursement for Advanced Diagnostics Track and the Precision Medicine tracks at the upcoming Next-Generation Diagnostic Summit that is held from August 20th to the 24th in Washington, D.C
 
Topics include the chicken-or-the-egg conundrum of building evidence and gaining access, a study looking at the cost effectiveness of using NGS for clinical practice, challenges in the diagnostic reimbursement community and more.  For more information, please visit http://www.NextGenerationDX.com/Reimbursement-Diagnostics/ and http://www.NextGenerationDX.com/Precision-Medicine/

Next Generation DX Summit 2018 | the Value of NGS-based Diagnostic Testing for Lung Cancer Patients

Dr. Bruce Quinn talks about his latest work, challenges to implementing precision medicine, advice for overcoming them and tips for integrating into the clinic. He discusses exciting new developments that are emerging and where the field is heading.

For more information, please visit http://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics/

Next Generation Dx Summit 2018 | Molecular Diagnostics in Precision Medicine and Healthcare

Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California
Dr. Jennifer Dien Bard shares her insights into what the biggest challenges and opportunities are in implementing molecular point-of-care testing for infectious disease diagnostics, and rapid genetic and phenotypic susceptibility testing. Jennifer will be speaking at Molecular Diagnostics for Infectious Disease and co-instructing a short course on Rapid Diagnostics for Antimicrobial Resistance at the Next Generation Dx Summit August 20 to 24, 2018 in Washington, DC.

For more information please visit http://www.NextGenerationDX.com/Infectious-Disease-Diagnostics/ and http://www.NextGenerationDX.com/SC-6/

Next Generation DX Summit 2018 |  Challenges and Opportunities in Molecular Testing

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.